Latest Blogs

Nov 21, 2019
Dr. Clarissa Mathias, chair-elect of ASCO's International Affairs Committee, speaks to the incredible impact that ASCO volunteers have on cancer care around the world.
Nov 19, 2019
Dr. Aditya Bardia and I discuss the deep and sincere bonds we form not just with our patients but with their families. How can we ensure their needs are met, especially after a patient dies?
Nov 14, 2019
If you have a passion and a calling, writes Ms. Bincy Mathew, don't let the fear of what others might think keep you from achieving your goals.
Nov 13, 2019
He was lonely and afraid after a diagnosis of prostate cancer, and I hope, wherever he is, that he is doing well.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Feb 16, 2016
In what is the first (and hopefully one of many) example of using modern genomic methods to match treatments to the molecular defects in prostate cancer, the U.S. FDA has just granted “breakthrough designation” to olaparib.
Jan 06, 2016
One of the most frequent questions I hear in my clinic is, “Are we making any progress?” or, “Is there anything new out there?” The answer is always yes, or more properly, YES!
Nov 04, 2015
I think the facet of cancer most commonly misunderstood by non-scientists (patients/families) is heterogeneity. Several presentations at the Prostate Cancer Foundation Annual Retreat touched on this theme.
Aug 05, 2015
Looking back on the 1976 Bonadonna study using CMF chemotherapy in women with breast cancer and positive axillary nodes, I consider what went wrong in the search for similarly effective treatment of prostate cancer.
Jun 03, 2015
As someone who is interested in prostate cancer almost exclusively in my practice, listening to Dr. Nicholas James present the data from the STAMPEDE trial was of high interest.
May 31, 2015
I listened to some of my favorite presenters in my field of interest and got to sample some wonderful biology I would most certainly have missed.

Pages